ABSTRACT
In the present study, we investigated the protein levels and phosphorylation status of the insulin receptor and insulin receptor substrates (IRS-1, IRS-2, and IRS-3) as well as their association with PI(3)-kinase in the rat adipose tissue of two models of insulin resistance: dexamethasone treatment and aging. AKT and atypical PKC phosphorylation detection were also performed. Both models showed decreased insulin-induced IRS-1 and IRS-2 tyrosine phosphorylation, accompanied by reduced protein levels of IRS-1 and IRS-2. Nevertheless, IRS-3 protein level was unchanged in aging but increased in dexamethasone-treated rats. PI(3)-kinase association with IRS-1 was reduced in aged rats, whereas dexamethasone-treated rats showed a reduced IRS-2/ PI(3)-kinase association. However, IRS-3 association with PI(3)-kinase was reduced in both models, as well as insulin-induced AKT and PKC phosphorylation. The alterations described in the present study show that the action of insulin is differently impaired depending on the origin of insulin resistance. These differences might be directly linked to the singular metabolic features of the models we tested.
Subject(s)
Adipose Tissue/metabolism , Aging/physiology , Dexamethasone/pharmacology , Intracellular Signaling Peptides and Proteins/metabolism , Obesity/metabolism , Phosphoproteins/metabolism , Adipose Tissue/drug effects , Animals , Blood Glucose/analysis , Body Weight , Insulin/blood , Insulin Receptor Substrate Proteins , Insulin Resistance , Isoenzymes/metabolism , Male , Phosphatidylinositol 3-Kinases/metabolism , Phosphorylation , Protein Kinase C/metabolism , Rats , Rats, Wistar , Receptor, Insulin/metabolism , Signal Transduction/drug effectsABSTRACT
Polycystic ovary syndrome (PCOS) manifests as chronic anovulation, ovarian hyperandrogenism, and follicular cysts, which are amplified by insulin as well as the inability of the hormone to stimulate glucose uptake in classic target tissues such as muscle and fat. In the present study, we evaluated the regulation of the insulin-signaling pathways by using immunoprecipitation and immunoblotting in whole extracts of ovaries from non-pregnant human chorionic gonadotropin (hCG)-treated rats, hyperinsulinemic-induced rats and hyperinsulinemic-induced rats, treated with hCG for 22 consecutive days. There were increased associations of insulin receptor substrate (IRS)-1 and IRS-2 with phosphatidylinositol (PI) 3-kinase, followed by enhanced protein kinase B (Akt) serine and threonine phosphorylation, in the ovaries of rats that were treated with hCG, either alone or with insulin. In contrast, the skeletal muscle demonstrated a reduced IRS-1/PI 3-kinase/Akt pathway in hyperinsulinemic-induced rats. These intracellular modifications were accompanied by follicular cysts, detected by optical microscopy, and increased androstenedione serum levels. In summary, our data show that chronic treatment with hCG or hCG plus insulin can induce changes in ovaries that simulate PCOS. In these situations, an increase in the insulin-induced IRS/PI 3-kinase/Akt pathway occurs in the ovary, suggesting that the activation of this pathway may have a role in the development of PCOS.
Subject(s)
Chorionic Gonadotropin/pharmacology , Insulin/pharmacology , Phosphatidylinositol 3-Kinases/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Signal Transduction/drug effects , Up-Regulation , Animals , Extracellular Signal-Regulated MAP Kinases/analysis , Female , Immunoblotting/methods , Insulin Receptor Substrate Proteins , Intracellular Signaling Peptides and Proteins/analysis , Oncogene Protein v-akt/analysis , Phosphoproteins/analysis , Rats , Rats, Wistar , Receptor, Insulin/analysisABSTRACT
The effect of dehydroepiandrosterone (DHEA) on pancreatic islet function of aged rats, an animal model with impaired glucose-induced insulin secretion, was investigated. The following parameters were examined: morphological analysis of endocrine pancreata by immunohistochemistry; protein levels of insulin receptor, IRS-1, IRS-2, PI 3-kinase, Akt-1, and Akt-2; and static insulin secretion in isolated pancreatic islets. Pancreatic islets from DHEA-treated rats showed an increased beta-cell mass accompanied by increased Akt-1 protein level but reduced IR, IRS-1, and IRS-2 protein levels and enhanced glucose-stimulated insulin secretion. The present results suggest that DHEA may be a promising drug to prevent diabetes during aging.
Subject(s)
Adjuvants, Immunologic/administration & dosage , Aging/metabolism , Cell Size/drug effects , Dehydroepiandrosterone/administration & dosage , Insulin-Secreting Cells/metabolism , Insulin/metabolism , Aging/drug effects , Aging/pathology , Animals , Diabetes Mellitus/drug therapy , Diabetes Mellitus/metabolism , Humans , Immunohistochemistry , Insulin Receptor Substrate Proteins , Insulin Secretion , Insulin-Secreting Cells/pathology , Intracellular Signaling Peptides and Proteins , Male , Phosphatidylinositol 3-Kinases/biosynthesis , Phosphoproteins/biosynthesis , Proto-Oncogene Proteins c-akt , Rats , Rats, WistarABSTRACT
Melatonin is the pineal hormone that acts via a pertussis toxin-sensitive G-protein to inhibit adenylate cyclase. However, the intracellular signalling effects of melatonin are not completely understood. Melatonin receptors are mainly present in the suprachiasmatic nucleus (SCN) and pars tuberalis of both humans and rats. The SCN directly controls, amongst other mechanisms, the circadian rhythm of plasma glucose concentration. In this study, using immunoprecipitation and immunoblotting, we show that melatonin induces rapid tyrosine phosphorylation and activation of the insulin receptor beta-subunit tyrosine kinase (IR) in the rat hypothalamic suprachiasmatic region. Upon IR activation, tyrosine phosphorylation of IRS-1 was detected. In addition, melatonin induced IRS-1/PI3-kinase and IRS-1/SHP-2 associations and downstream AKT serine phosphorylation and MAPK (mitogen-activated protein kinase) phosphorylation, respectively. These results not only indicate a new signal transduction pathway for melatonin, but also a potential cross-talk between melatonin and insulin.
